The effectiveness of therapy depends upon accurate diagnosis of the precise type of MD, so physicians here may use advanced diagnostic techniques such as genetic analysis and biopsy of muscle or nerve tissue to pinpoint the type of neuromuscular disease or myopathy. Through this program, patients here have access to the most innovative treatments and therapies. The MDA also provides educational support and financial resources for wheelchairs and for travel expenses related to physician visits and physical therapy. University of Chicago neurologists have extensive experience treating patients with various forms of muscular dystrophy and myopathy. In addition to working with patients, these physicians are active in laboratory research that may offer new hope for people with muscular dystrophy and other myopathies.
Social workers are a critical element of the care team.
Because neuromuscular diseases affect so many aspects of a person's life and lifestyle, this support can enhance a person's function and independence. Older patients with muscular dystrophy often work with a University of Chicago neurologist who has expertise in geriatric muscular dystrophy. Clinical trials Patients may be eligible for the newest, investigational therapies which are available through clinical trials . One current, multicenter study is looking at new treatments for heart disorders associated with muscular dystrophy. U of C Research in Muscular Dystrophy University of Chicago faculty physicians are studying the process of neurodegenerative diseases, including methods that may enhance survival of nerves important to maintaining the health of muscles.